News

A peer reviewed paper, ‘Improving clinical research through better use of clinical trial registry data’, has been published in The Lancet Digital Health. The paper reflects insights gathered through the ACT EU multi stakeholder workshop on clinical trials analytics.

Stakeholder organisations are invited to nominate representatives for the next mandate of the ACT EU Multi-stakeholder Platform Advisory Group (MSP AG). The deadline for submissions is 30 October 2026.

19 multinational clinical trials have been authorised in addition to the historical average; 40.5% of the total number of clinical trials recruit participants within 200 days.

The ACT EU workplan for 2026-2027 outlines the initiative's revised objectives and areas of focus, informed by feedback from stakeholders.

Recommendations to streamline authorisation of new clinical trials and changes to ongoing trials to generate clinical evidence

The outcome report from the 2025 annual Multi-stakeholder platform meeting on innovation is now available.

New approach brings together clinical trial and ethics expertise to accelerate development of medicines for use ahead of or during emergencies

Following consultation with the Multi-stakeholder platform Advisory Group, new documents have been published to support sponsors in the implementation of the Clinical Trials Regulation (CTR).

500 authorised multinational clinical trials to be added over five years

COMBINE “all-in-one” coordinated assessment pilot: call open for expressions of interest until 31 August 2025.